Want to see AU:EPN full AI Analyst Report?
EPN Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume257.46K
Average Volume (3M)0.00
Market Cap
AU$9.73M
Enterprise ValueAU$22.62
Total Cash (Recent Filing)AU$242.86K
Total Debt (Recent Filing)AU$10.35M
Price to Earnings (P/E)―
Beta-0.25
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding389,104,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)6.55
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA ~53% revenue rebound in 2025 shows meaningful top-line recovery versus prior years. Sustained revenue growth over several quarters would support scale, improve fixed-cost absorption and create a clearer path to operating leverage, reducing execution risk over the next 2–6 months.
Gross Profit PositiveRecording positive gross profit in 2025 indicates the core product economics now cover direct production costs. If maintained, this underpins margin expansion potential as SG&A is optimized, providing a durable foundation for eventual operating profitability and better cash conversion.
Improving Cash Flow TrendAlthough still negative, the improvement in free cash flow versus 2024 signals progress in cash conversion and lower cash burn. A continued trend of less negative cash flow reduces near-term financing needs and increases resilience over the coming months if management sustains operational improvements.
Bears Say
Persistent UnprofitabilityMaterial and persistent negative operating profit and a net margin near -22% indicate the company has not yet achieved sustainable earnings. Continued losses erode retained capital, constrain reinvestment, and require external funding or dilution to sustain growth over the medium term.
Weak Cash GenerationConsistently negative operating and free cash flows across years demonstrate structural cash burn. This elevates refinancing and liquidity risk, limits ability to fund R&D or commercial expansion internally, and makes the company reliant on external capital injections over the next 2–6 months.
High LeverageA sharp rise in leverage to roughly 4.7x debt/equity while equity shrank materially reduces financial flexibility. High leverage increases servicing and refinancing risk for an unprofitable company, raising the chance of covenant pressure or costly funding needs in the near-to-medium term.
Epsilon Healthcare Limited News
EPN FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is AU$9.73M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Sep 02, 2026 which is in 25 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Feb 27, 2026. The company reported AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in AU:EPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
84.04%
Trailing 12-Months
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several areas: manufacturing and distributing a range of hydroponic supplies, including equipment, materials, and vital nutrients; developing and providing medicinal cannabis products; and offering comprehensive, ready-to-implement solutions for cannabis cultivation. The company officially rebranded from THC Global Group Limited to Epsilon Healthcare Limited in February 2021.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―